A detailed history of Grove Bank & Trust transactions in Insulet Corp stock. As of the latest transaction made, Grove Bank & Trust holds 34 shares of PODD stock, worth $11,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 34 -0.0%
Holding current value
$11,311
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 10, 2025

BUY
$238.57 - $327.47 $1,669 - $2,292
7 Added 25.93%
34 $10,000
Q4 2024

Jan 16, 2025

BUY
$227.79 - $275.7 $2,505 - $3,032
11 Added 68.75%
27 $7,000
Q3 2024

Oct 11, 2024

BUY
$180.69 - $239.01 $2,891 - $3,824
16 New
16 $3,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $23.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.